EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a significant drop in short interest in February. As of February 27th, there was short interest totaling 81,625 shares, a drop of 44.0% from the February 12th total of 145,762 shares. Based on an average daily trading volume, of 21,902 shares, the short-interest ratio is presently 3.7 days. Approximately 0.2% of the shares of the stock are short sold. Approximately 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 21,902 shares, the short-interest ratio is presently 3.7 days.

Hedge Funds Weigh In On EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC acquired a new stake in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health at the end of the most recent quarter. 4.35% of the stock is currently owned by institutional investors and hedge funds.

EUDA Health Stock Down 2.1%

NASDAQ:EUDA traded down $0.01 during midday trading on Friday, hitting $0.49. The company had a trading volume of 118,432 shares, compared to its average volume of 136,321. The company has a market capitalization of $18.55 million, a PE ratio of -4.09 and a beta of -0.11. EUDA Health has a 52-week low of $0.46 and a 52-week high of $4.30. The stock’s fifty day moving average price is $1.25 and its 200-day moving average price is $1.97.

Analysts Set New Price Targets

EUDA has been the topic of several recent analyst reports. Greenridge Global lowered their price target on EUDA Health from $6.00 to $2.75 and set a “buy” rating on the stock in a report on Monday, March 9th. Weiss Ratings restated a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $2.75.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.